Ningbo Menovo Pharmaceutical Co (SHSE:603538) Long-Term Capital Lease Obligation : ¥14 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Ningbo Menovo Pharmaceutical Co Long-Term Capital Lease Obligation?

Ningbo Menovo Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥14 Mil.

Ningbo Menovo Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 (¥15 Mil) to Dec. 2024 (¥12 Mil) but then increased from Dec. 2024 (¥12 Mil) to Mar. 2025 (¥14 Mil).

Ningbo Menovo Pharmaceutical Co's annual Long-Term Capital Lease Obligation declined from Dec. 2022 (¥30 Mil) to Dec. 2023 (¥16 Mil) and declined from Dec. 2023 (¥16 Mil) to Dec. 2024 (¥12 Mil).

Ningbo Menovo Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Ningbo Menovo Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ningbo Menovo Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Ningbo Menovo Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

26.84

28.03

30.34

15.69

12.35

Ningbo Menovo Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															18.15	14.94	14.92	12.35	14.40

Ningbo Menovo Pharmaceutical Co (SHSE:603538) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Ningbo Menovo Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Ningbo Menovo Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Ningbo Menovo Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ningbo Menovo Pharmaceutical Co Ltd (SHSE:603538) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040

Website

http://www.menovopharm.com

Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.

Executives

Xu Jian	senior management
Cao Qian	Director
Yao Fang	Director
Ying Gao Feng	Director
Sun Yan	Director
Shi Jian Xiang	Director
Wu Feng Yun	Director
Tu Ying	Director
Yao Cheng Zhi	Director
Zheng Hui Lin	Supervisors
Jiao Hua	senior management

Ningbo Menovo Pharmaceutical Co Headlines

No Headlines